The patient exhibited intrinsic refractoriness to sequential conventional therapies, including pazopanib, everolimus, and high-dose interleukin-2, resulting in rapid multiorgan dissemination of cancer cells after pulmonary metastectomy (Fig. 1a). The gene discussed is IL2; the disease is cancer.